Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
作者信息
Theile Dirk, Czock David
机构信息
Internal Medicine IX, Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
出版信息
Ann Surg Oncol. 2024 Dec;31(13):8614-8615. doi: 10.1245/s10434-024-16060-8. Epub 2024 Aug 17.
Abstract
摘要
相似文献
1
Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?灌注液流速：热灌注化疗（HIPEC）中一个被忽视的因素？
Ann Surg Oncol. 2024 Dec;31(13):8614-8615. doi: 10.1245/s10434-024-16060-8. Epub 2024 Aug 17.
2
Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model.灌注液浓度对啮齿动物模型高热腹腔化疗疗效和毒性的影响。
J Surg Res. 2020 Sep;253:262-271. doi: 10.1016/j.jss.2020.03.067. Epub 2020 May 7.
3
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C.含丝裂霉素 C 的细胞减灭术和腹腔热灌注化疗（CS-HIPEC）后灌洗液的抗菌性能。
Ann Surg Oncol. 2017 Dec;24(13):3837-3841. doi: 10.1245/s10434-017-6113-y. Epub 2017 Oct 10.
4
A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology.妇科肿瘤学中建立腹腔内热化疗方案的指南。
Gynecol Oncol. 2020 Sep;158(3):794-802. doi: 10.1016/j.ygyno.2020.06.487. Epub 2020 Jul 2.
5
Impact of Perfusate Glucose Concentration on Perioperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.灌洗液葡萄糖浓度对细胞减灭术和腹腔热灌注化疗患者围手术期结局的影响。
J Surg Res. 2020 Dec;256:206-211. doi: 10.1016/j.jss.2020.06.055. Epub 2020 Jul 22.
6
Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔热灌注化疗后急性肾功能损害的危险因素。
Int J Hyperthermia. 2020;37(1):1279-1286. doi: 10.1080/02656736.2020.1846793.
7
Pharmacokinetics and toxicity of carboplatin used for hyperthermic intraperitoneal chemotherapy (HIPEC) in treatment of epithelial ovarian cancer.用于上皮性卵巢癌热灌注化疗（HIPEC）的卡铂的药代动力学及毒性
Pleura Peritoneum. 2020 Sep 7;5(4):20200137. doi: 10.1515/pp-2020-0137. eCollection 2020 Nov.
8
Intra-abdominal temperature variation during hyperthermic intraperitoneal chemotherapy evaluated via computational fluid dynamics modeling.通过计算流体动力学建模评估热腹腔内化疗期间的腹腔内温度变化。
J Gastrointest Oncol. 2024 Aug 31;15(4):1847-1860. doi: 10.21037/jgo-24-352. Epub 2024 Aug 28.
9
10
The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial).紫杉醇腹腔热灌注化疗治疗晚期高级别浆液性卵巢癌的影响：一项随机对照试验（C-HOC 试验）的安全性和即刻疗效的中期分析。
J Ovarian Res. 2024 Jul 12;17(1):145. doi: 10.1186/s13048-024-01468-3.
本文引用的文献
1
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies.2022 年 PSOGI 国际腹膜恶性肿瘤 HIPEC 方案共识：HIPEC 技术。
Ann Surg Oncol. 2024 Oct;31(10):7090-7110. doi: 10.1245/s10434-024-15513-4. Epub 2024 Jul 22.
2
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies.高热在腹膜表面恶性肿瘤治疗中的作用。
Curr Oncol Rep. 2022 Jul;24(7):875-887. doi: 10.1007/s11912-022-01275-3. Epub 2022 Mar 24.
3
Pharmacological principles of intraperitoneal and bidirectional chemotherapy.腹腔内及双向化疗的药理学原理
Pleura Peritoneum. 2017 Jun 1;2(2):47-62. doi: 10.1515/pp-2017-0010. Epub 2017 Apr 29.
4
Exploring flow rate selection in HIPEC procedures.探讨热灌注化疗（HIPEC）手术中流速的选择。
Rev Col Bras Cir. 2016 Dec;43(6):476-479. doi: 10.1590/0100-69912016006014.
5
Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion.更高的流速可改善高热腹腔内热化疗期间的加热效果。
J Surg Oncol. 2014 Dec;110(8):970-5. doi: 10.1002/jso.23776. Epub 2014 Aug 29.
6
Drug transporters of platinum-based anticancer agents and their clinical significance.铂类抗癌药物的药物转运体及其临床意义。
Drug Resist Updat. 2011 Feb;14(1):22-34. doi: 10.1016/j.drup.2010.12.002. Epub 2011 Jan 20.
7
Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients.口服或静脉注射顺铂后铂的药代动力学：一项针对32例成年患者的1期研究。
Cancer Chemother Pharmacol. 2005 Jan;55(1):55-60. doi: 10.1007/s00280-004-0852-8. Epub 2004 Jul 28.
8
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis.
J Clin Pharmacol. 1999 Apr;39(4):394-401. doi: 10.1177/00912709922007967.
9
Oral sustained-release cisplatin preparation for rats and mice.
J Pharm Pharmacol. 1997 May;49(5):485-90. doi: 10.1111/j.2042-7158.1997.tb06828.x.
Zotero 插件